BARCELONA, Spain – Saturday 30 August: The anti-inflammatory drug colchicine is not an effective treatment for cardiac patients who develop a condition called post-operative pericardial effusion (POPE) – a build-up of fluid around the heart, according to a new study. The POPE-2 study, presented as a Hot Line today at the ESC Congress 2014, and published simultaneously in the European Heart Journal, is the second study that has failed to identify a medical treatment for POPE, a potentially serious condition that can lead to the life-threatening complication of cardiac tamponade.
Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...
Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...